Visual function following photodynamic therapy for central serous chorioretinopathy: A comparison of automated macular microperimetry versus best-corrected visual acuity

Clinical and Experimental Ophthalmology

Volumn 40, Issue 1, 2012, Pages

  Ehrlich, Rita ^a   Mawer, Nick P ^b   Mody, Christopher H ^b   Brand, Christopher S ^b   Squirrell, David ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Central serous chorio retinopathy; Microperimetry; Photodynamic therapy

Indexed keywords

VERTEPORFIN;

ADULT; AGED; ARTICLE; AUTOMATED MACULAR MICROPERIMETRY; BEST CORRECTED VISUAL ACUITY; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SUBRETINAL FLUID; THERAPY EFFECT; VISION; VISION TEST; VISUAL ACUITY;

ADULT; AGED; CENTRAL SEROUS CHORIORETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; RETINA; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84856634204     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2011.02654.x     Document Type: Article

References (22)

1. Yannuzzi LA. Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 2010; 149: 361-3.
2. Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol 2008; 86: 126-45.
3. Reibaldi M, Cardascia N, Longo A etal. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol 2010; 149: 307-15.
4. Folk JC, Thompson HS, Han DP, Brown CK. Visual function abnormalities in central serous retinopathy. Arch Ophthalmol 1984; 102: 1299-302.
5. Chuang EL, Sharp DM, Fitzke FW, Kemp CM, Holden AL, Bird AC. Retinal dysfunction in central serous retinopathy. Eye 1987; 1: 120-5.
6. Miyake Y, Shiroyama N, Ota I, Horiguchi M. Local macular electroretinographic responses in idiopathic central serous chorioretinopathy. Am J Ophthalmol 1988; 106: 546-50.
7. Nagata M, Honda Y. Macular ERG in central serous retinopathy. Jpn J Ophthalmol 1971; 15: 9-16.
8. Toonen F, Remky A, Janssen V, Wolf S, Reim M. Microperimetry in patients with central serous retinopathy. Ger J Ophthalmol 1995; 4: 311-14.
9. Ozdemir H, Karacorlu SA, Senturk F, Karacorlu M, Uysal O. Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy. Eye 2008; 22: 204-8.
10. Frisen L, Frisen M. Micropsia and visual acuity in macular edema: a study of the neuro-retinal basis of visual acuity. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1979; 2: 69-77.
11. Piccolino FC, de la Longrais RR, Ravera G etal. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 2005; 139: 87-99.
12. Fletcher DC, Schuchard RA. Visual function in patient's with choroirdal neovascularization resulting from age related macular degeneration: the importance of looking beyond visual acuity. Optom Vis Sci 2006; 83: 178-89.
13. Springer C, Bültmann S, Völcker HE, Rohrschneider K. Fundus perimetry with the Micro Perimeter 1 in normal individuals: comparison with conventional threshold perimetry. Ophthalmology 2005; 112: 848-54.
14. Rohrschneider K, Springer C, Bültmann S, Völcker HE. Microperimetry-comparison between the micro perimeter 1 and scanning laser ophthalmoscope - fundus perimetry. Am J Ophthalmol 2005; 139: 125-34.
15. Squirrell DM, Mawer NP, Mody CH, Brand CS. Visual outcome after intravitreal ranibizumab for wet age-related macular degeneration: a comparison between best-corrected visual acuity and microperimetry. Retina 2010; 30: 436-42.
16. Okada K, Yamamoto S, Mizunoya S, Hoshino A, Arai M, Takatsuna Y. Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema. Eye (Lond) 2006; 20: 805-9.
17. Richter-Mueksch S, Ve'csei-Marlovits PV, Sacu SG, Kiss CG, Weingessel B, Schmidt-Erfurth U. Functional macular mapping in patients with vitreomacular pathologic features before and after surgery. Am J Ophthalmol 2007; 144: 23-31.
18. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. TAP report. Arch Ophthalmol 1999; 117: 1329-45.
19. Ojima Y, Tsujikawa A, Hangai M etal. Retinal sensitivity measured with the micro perimeter 1year after resolution of central serous chorioretinopathy. Am J Ophthalmol 2008; 146: 77-84.
20. Senturk F, Karacorlu M, Ozdemir H, Karacorlu SA, Uysal O. Microperimetric changes after photodynamic therapy for central serous chorioretinopathy. Am J Ophthalmol 2011; 151: 303-9.
21. Fujita K, Yuzawa M, Mori R. Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results. Retina 2011; 31: 772-8.
22. Chen FK, Patel PJ, Xing W etal. Test-retest variability of microperimetry using the Nidek MP1 in patients with macular disease. Invest Ophthalmol Vis Sci 2009; 50: 3464-72.